Association between human leukocyte antigen class I and II alleles and hepatitis C virus infection in high-risk hemodialysis patients awaiting kidney transplantation

Human Immunology

Volumn 74, Issue 12, 2013, Pages 1629-1632

  Grimaldi, Vincenzo ^a   Sommese, Linda ^a   Picascia, Antonietta ^a   Casamassimi, Amelia ^a   Cacciatore, Francesco ^b   Renda, Andrea ^c   De Rosa, Paride ^d   Montesano, Maria Lourdes ^a   Sabia, Chiara ^a   Fiorito, Carmela ^a   De Iorio, Gustavo ^a   Napoli, Claudio ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b IRCCS   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY HOSPITAL SAN GIOVANNI DI DIO E RUGGI D ARAGONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DRB1 ANTIGEN;

ADULT; ANTIBODY DETECTION; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS PATIENT; HEPATITIS C; HEREDITY; HIGH RISK PATIENT; HLA TYPING; HUMAN; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL;

CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY; CI; CMIA; CONFIDENCE INTERVALS; HCV; HEPATITIS C VIRUS; NATURAL KILLER; NK; ODDS RATIOS; OR; RECOMBINANT IMMUNOBLOT ASSAY; RIBA; SPSS; STATISTICAL PACKAGE OF SOCIAL SCIENCE;

AGE FACTORS; AGED; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HEPACIVIRUS; HEPATITIS C; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; ODDS RATIO; RENAL DIALYSIS; SEX FACTORS;

EID: 84888200847     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.08.008     Document Type: Article

References (42)

1. Lauer G.M., Walker B.D. Hepatitis C virus infection. N Engl J Med 2001, 345:41-52.
2. Fabrizi F., Dixit V., Messa P. Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?. J Viral Hepat 2012, 19:601-607.
3. Fissell R.B., Bragg-Gresham J.L., Woods J.D., Jadoul M., Gillespie B., Hedderwick S.A., et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2004, 65:2335-2342.
4. Carbone M., Cockwell P., Neuberger J. Hepatitis C and kidney transplantation. Int J Nephrol 2011, 2011:593291. 10.4061/2011/593291.
5. Wolfe R.A., Ashby V.B., Milford E.L., Ojo A.O., Ettenger R.E., Agodoa L.Y., et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999, 341:1725-1730.
6. Perlman R.L., Finkelstein F.O., Liu L., Roys E., Kiser M., Eisele G., et al. Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the renal research institute-C0KD study. Am J Kidney Dis 2005, 45:658-666.
7. Li Cavoli G., Ferrantelli A., Bono L., Tortorici C., Giammarresi C., Zagarrigo C., et al. Incidence of hepatitis C virus infection in patients with chronic kidney disease on conservative therapy. Int J Infect Dis 2011, 15:e514-6.
8. Fabrizi F., Lunghi G., Ganeshan S.V., Martin P., Messa P. Hepatitis C virus infection and the dialysis patient. Semin Dial 2007, 20:416-422.
9. Fabrizi F., Takkouche B., Lunghi G., Dixit V., Messa P., Martin P. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies. J Viral Hepat 2007, 14:697-703.
10. Spaan M., Janssen H.L., Boonstra A. Immunology of hepatitis C virus infections. Best Pract Res Clin Gastroenterol 2012, 26:391-400.
11. Amini M., Poustchi H. Hepatitis C virus spontaneous clearance: immunology and genetic variance. Viral Immunol 2012, 25:241-248.
12. Lloyd A.R., Jagger E., Post J.J., Crooks L.A., Rawlinson W.D., Hahn Y.S., et al. Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection. Immunol Cell Biol 2007, 85:24-32.
13. Elahi S., Horton H. Association of HLA-alleles with the immune regulation of chronic viral infections. Int J Biochem Cell Biol 2012, 44:1361-1365.
14. Marangon A.V., Silva G.F., de Moraes C.F., Grotto R.M., Pardini M.I., de Pauli D.S., et al. KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C. Hum Immunol 2011, 72:1074-1078.
15. Singh R., Kaul R., Kaul A., Khan K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 2007, 13:1770-1787.
16. Vidal S.M., Khakoo S.I., Biron C.A. Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience. Curr Opin Virol 2011, 1:497-512.
17. Khakoo S.I., Thio C.L., Martin M.P., Brooks C.R., Gao X., Astemborski J., et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004, 305:872-874.
18. Chang K.M., Thimme R., Melpolder J.J., Oldach D., Pemberton J., Moorhead-Loudis J., et al. Differential CD4 (+) and CD 8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology 2001, 33:267-276.
19. Ciuffreda D., Kim A.Y. Update on hepatitis C virus-specific immunity. Curr Opin HIV AIDS 2011, 6:559-565.
20. Cangussu L.O., Teixeira R., Campos E.F., Rampim G.F., Mingoti S.A., Martins-Filho O.A., et al. HLA class II alleles and chronic hepatitis C virus infection. Scand J Immunol 2011, 74:282-287.
21. Vejbaesya S., Songsivilai S., Tanwandee T., Rachaibu S., Chantangpol R., Dharakul T. HLA association with hepatitis C virus infection. Hum Immunol 2000, 61:348-353.
22. El-Chennawi F.A., Auf F.A., Metwally S.S., Mosaad Y.M., El-Wahab M.A., Tawhid Z.E. HLA-class II alleles in Egyptian patients with hepatocellular carcinoma. Immunol Invest 2008, 37:661-674.
23. Hadhoud A., Abdulaziz A.M., Menawi L.A., Shaheen F.A., Abdulghaffar A., Abas F.A., et al. The relationship between HLA typing and HCV infection and outcome of renal transplantation in HCV positive patients. Exp Clin Transplant 2003, 1:19-25.
24. * allele and haplotype association with hepatitis C virus persistence and clearance. J Gen Virol 2010, 91(Pt 8):1931-1938.
25. Cursino-Santos J.R., Donadi E.A., Martinelli A.L., Louzada-Junior P., Martinez-Rossi N.M. Evolution of hepatitis C virus infection under host factor influence in an ethnically complex population. Liver Int 2007, 27:1371-1378.
26. Wang J.H., Zheng X., Ke X., Dorak M.T., Shen J., Boodram B., et al. Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infection. Virol J 2009, 6:46.
27. Terasaki P.I., McClelland J.D. Microdroplet assay of human serum cytotoxins. Nature 1964, 204:998-1000.
28. Minucci P.B., Grimaldi V., Casamassimi A., Cacciatore F., Sommese L., Picascia A., et al. Methodologies for anti-HLA antibody screening in patients awaiting kidney transplant: a comparative study. Exp Clin Transplant 2011, 9:381-386.
29. Marangon A.V., Silva G.F., de Moraes C.F., Grotto R.M., Pardini M.I., de Pauli D.S., et al. Protective effect of HLA-DRB1 11 and predisposition of HLA-C 04 in the development of severe liver damage in Brazilian patients with chronic hepatitis C virus infection. Scand J Immunol 2012, 76:440-447.
30. McKiernan S.M., Hagan R., Curry M., McDonald G.S., Kelly A., Nolan N., et al. Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 2004, 40:108-114.
31. Thio C.L., Thomas D.L., Goedert J.J., Vlahov D., Nelson K.E., Hilgartner M.W., et al. Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis 2001, 184:16-21.
32. Verdon R., Pol S., Landais P., Mattlinger B., Carnot F., Brechot C., et al. Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patients. J Hepatol 1994, 21:388-393.
33. Dinçer D., Besisik F., Oǧuz F., Sever M.S., Kaymakoglu S., Cakaloglu Y., et al. Genes of major histocompatibility complex class II influence chronic C hepatitis treatment with interferon in hemodialysis patients. Int J Artif Organs 2001, 24:212-214.
34. Shaheen N.M., Soliman A.R., El-Khashab S.O., Hanna M.O. HLA DRB1 alleles and hepatitis C virus infection in chronic kidney disease patients. Ren Fail 2013, 35:386-390.
35. Fanning L.J., Kenny-Walsh E., Shanahan F. Persistence of hepatitis C virus in a white population: associations with human leukocyte antigen class 1. Hum Immunol 2004, 65:745-751.
36. Mosaad Y.M., Farag R.E., Arafa M.M., Eletreby S., El-Alfy H.A., Eldeek B.S., et al. Association of human leucocyte antigen Class I (HLA-A and HLA-B) with chronic hepatitis C virus infection in Egyptian patients. Scand J Immunol 2010, 72:548-553.
37. Zavaglia C., Martinetti M., Silini E., Bottelli R., Daielli C., Asti M., et al. Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. J Hepatol 1998, 28:1-7.
38. Asti M., Martinetti M., Zavaglia C., Cuccia M.C., Gusberti L., Tinelli C., et al. Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease. Hepatology 1999, 29:1272-1279.
39. Scotto G., Fazio V., D'Alessandro G., Monno L., Saracino A., Palumbo E., et al. Association between HLA class II antigens and hepatitis C virus infection. J Biol Regul Homeost Agents 2003, 17:316-321.
40. Zekri A.R., El-Mahallawy H.A., Hassan A., El-Din N.H., Kamel A.M. HLA alleles in Egyptian HCV genotype-4 carriers. Egypt J Immunol 2005, 12:77-86.
41. *01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin. J Hepatol 1999, 30:979-983.
42. Barrett S., Sweeney M., Crowe J. Host immune responses in hepatitis C virus clearance. Eur J Gastroenterol Hepatol 2005, 17:1089-1097.